Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis-Reference-Cited by-同舟云学术

Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis

Published:2012-09 Issue:9 Volume:40 Page:771-780.e19
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Skov Vibe,Thomassen Mads,Riley Caroline H.,Jensen Morten K.,Bjerrum Ole Weis,Kruse Torben A.,Hasselbalch Hans Carl,Larsen Thomas Stauffer

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference50 articles.

1. Some speculations on the myeloproliferative syndromes;DAMESHEK;Blood,1951

2. A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders;Thiele;Leuk Lymphoma,2006

3. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes;Wilkins;Blood,2008

4. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study;Barbui;J Clin Oncol,2011

5. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman;Blood,2009

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis;Platelets;2024-02

2. TLR2 Derangements Likely Play a Significant Role in the Inflammatory Response and Thrombosis in Patients with Ph(−) Classical Myeloproliferative Neoplasm;Mediators of Inflammation;2024-01

3. TLR-2 derangements likely play a significant role in the inflammatory response and thrombosis in patients with Ph(-) classical myeloproliferative neoplasm;2023-09-18

4. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms;Cancers;2023-08-29

5. An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial;Frontiers in Immunology;2023-02-23